Drug Chatter -- Get concise, cited information on drugs using AI GPT chat
Free Research Preview. DrugChatter may produce inaccurate information.

Ask Questions, Get Industry Insights … Instantly


Save time and get answers to complex questions with AI chat

Recent Questions

Midazolam hcl coupon?
Ceftriaxone injection dose?
Accutane 30 mg price?
Generic for pristiq medication?
De10021667 acarbose us patent?

When was camzyos approved?

See the DrugPatentWatch profile for camzyos

When did the FDA approve Camzyos?

Camzyos (mavacamten) was approved by the FDA in April 2022. [1]

What was the approval for?

Camzyos is approved for adults with symptomatic NYHA class II–III obstructive hypertrophic cardiomyopathy (HCM). [1]

Sources

  1. DrugPatentWatch.com – Camzyos (mavacamten) Approval Information


Other Questions About Camzyos :

evaluate the cardiovascular therapeutics company camzyos on ecosystem & stakeholder influence what’s the average wholesale price of camzyos? evaluate the pharmaceutical company camzyos on my doctor prescribed camzyos. tell me about it. camzyos (mavacamten) evaluate the pharmaceutical company aficamten on my doctor prescribed camzyos. tell me about it. Is camzyos used for heart muscle thickening? What are the side effects of camzyos?